Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs
Naveen Narayanan, D.T. Nair
Topics & Concepts
ExoribonucleaseBiologyRNARitonavirBiochemistryGeneticsVirusGeneViral loadRNase PAntiretroviral therapySARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyRNA and protein synthesis mechanisms